학술논문
Zavegepant nasal spray for the acute treatment of migraine: A Phase 2/3 double-blind, randomized, placebo-controlled, dose-ranging trial
Document Type
Article
Author
Source
In: Headache . (Headache, October 2022, 62(9):1153-1163)
Subject
Language
English
ISSN
15264610
00178748
00178748